Hims & Hers Acquires Apostrophe
June 24, 2021
Hims & Hers Health, Inc. completed the acquisition of teledermatology specialist Apostrophe to deepen its personalized dermatology offering and integrate Apostrophe's clinical team and compounding pharmacy capabilities. The entire Apostrophe team will join Hims & Hers, with Apostrophe CEO Ben Holber becoming head of Hims & Hers' dermatology business line.
- Buyers
- Hims & Hers Health, Inc.
- Targets
- Apostrophe
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.